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Jacqueline Kreutzer, MDD espite application of multiple novel optionsfor treatment of pediatric pulmonary hy-pertension (PH) over the past 20 years, it
remains a serious life-threatening condition (1). Car-
diac catheterization plays a key role for diagnostic
precision and is considered the standard of care
before initiation of therapy and for ongoing evalua-
tion of therapeutic strategies (2). Acute pulmonary
vasoreactivity testing is important to determine prog-
nosis and a treatment plan. Complete anatomic and
physiological information is particularly essential
in the evaluation of PH associated with congenital
heart disease; however, as presented by O’Byrne
et al. (3) in this issue of the Journal, the procedure
carries a signiﬁcant risk of serious adverse events,
including cardiac arrest and death (2,3).SEE PAGE 1261Several institutions have reported their experience
on the safety of cardiac catheterization for pediatric
PH, showing variable rates of procedure-related death
and serious adverse events, ranging from 0% to 6%
(4,5). The MAGIC (Mid-Atlantic Group of Interven-
tional Cardiology) PH Registry (6) reported a serious
adverse event rate of 3.9% with no procedural deaths.
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These and other PH-speciﬁc registries have helped
expand knowledge on diagnosis, treatment protocols,
and disease epidemiology, highlighting differences
between adult and pediatric PH (1,2). Nevertheless,
there are drawbacks in the use of registry-based data,
because most patients enrolled may be at more
advanced stages of their disease process, resulting in
sampling bias by exclusion of those who may not
have survived at initial presentation, or with other
comorbidities or registry criteria exclusions.
In contrast to these institution-speciﬁc or disease-
speciﬁc registry reports, O’Byrne et al. (3) describe
results from analysis of hospital administrative data,
a multicenter retrospective cohort including 4,401
patients undergoing 6,339 procedures at 38 different
institutions in the United States, reporting to the
Pediatric Health Information Systems (PHIS) database
over a 5-year period. The strength of this report rests
on it being a large population-based study on pedi-
atric patients with PH of all types undergoing cathe-
terization during all hospitalizations entered in the
PHIS database during the study period. Overall, there
was a 3.3% risk of death or mechanical support within
1 day of cardiac catheterization. The risk was higher
at younger ages (premature neonates and infants)
and with cardiac surgery during the same admission,
prior heart transplantation, hemodialysis, or pre-
procedural use of intravenous systemic vasodilators.
The composite risk reported by O’Byrne et al. (3) is
higher than that reported for the general population
of pediatric patients having cardiac catheterization
(0.1%) (7). Most other studies have not reported spe-
ciﬁcally on the risk of initiation of mechanical support
but rather on cardiac arrest and mortality related to
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1271cardiac catheterization (8–10). The risk of death
before hospital discharge in the study by O’Byrne
et al. (6.6%) appears higher than the mortality risk
reported for cardiac catheterization in the past
(<0.5%) (8–10), as well as that reported for adults
with PH undergoing cardiac catheterization (<0.1%)
(11). Although the hospital mortality reported may not
necessarily be related to cardiac catheterization only,
it still represents a signiﬁcant ﬁnding.
The report by O’Byrne et al. (3) provides important
new insight about the actual risk of cardiac cathe-
terization in pediatric PH during hospital admissions.
As the authors point out, it is likely that the results
are representative of the real burden of disease that is
seen in current practice by tertiary care centers sub-
mitting data to PHIS. The large numbers allowed for
powerful statistical analyses to address potential
biases, including eliminating procedures in patients
who underwent operation within 1 day of cardiac
catheterization (to account for postoperative use of
extracorporeal membrane oxygenation) and restrict-
ing analysis to the ﬁrst catheterization for each
subject (excluding follow-up catheterizations) and
to those who did not have catheter intervention.
These demonstrated a similar standardized risk and
predictors as in the main analysis. In addition, the
association between catheterization laboratory an-
nual volume and the risk of composite outcome
was demonstrated, showing the highest risk (6.1%)
for the lowest volume, with a statistically signiﬁcant
association across quintiles. Of note, the authors have
recently reported a similar association between cen-
ter catheterization volumes and catastrophic events
within 1 day of cardiac catheterization based on
PHIS data (7). The latter also demonstrated that a
higher cardiac catheterization laboratory volume was
associated with reduced risk of catastrophic ad-
verse outcome in the immediate post-catheterization
period in children in general. This is in line with prior
ﬁndings for congenital heart surgery (12,13) and sug-
gests, “Practice makes perfect.” Nevertheless, the 2
studies raise awareness of the need to develop ap-
propriate health care strategies to provide the best
quality of care to children with serious congenital
cardiac conditions, because procedures in such pa-
tient populations are indeed risky.
It is important to point out the many limitations of
the study, particularly those inherent to the use of
the PHIS database, such as the lack of objective
hemodynamic data, procedural details, and other
pertinent patient information, which would allow for
risk stratiﬁcation and better prediction of risk factors
for life-threatening adverse events. Another signiﬁ-
cant concern is that the PHIS database does notcollect outpatient encounters. Outpatient catheteri-
zation procedures in those with milder disease
would have been excluded, resulting in a relatively
higher risk of adverse events. As opposed to regis-
tries, in which detailed data are collected by trained
data managers or clinicians, coding for administra-
tive hospital discharge data is performed by medical
records clerks or by billing personnel with variable
training and ability, using International Classiﬁca-
tion of Diseases, Ninth Revision codes. Accidental
miscoding, contradictory or poor information, and
lack of diagnostic speciﬁcity are known problems
inherent to hospital administrative data. Audits of
data coded in the PHIS database versus medical re-
cord review are not performed routinely. It has been
demonstrated that there are signiﬁcant differences in
case ascertainment between administrative and
clinical registry data for children undergoing cardiac
operations, which translates into important differ-
ences in outcomes assessment (14). Pasquali et al.
(12,14) challenged the idea that administrative data
could be used reliably to evaluate hospital perfor-
mance with regard to congenital heart surgery. It is
reasonable to expect that similar inaccuracies in case
ascertainment could be encountered with regard to
cardiac catheterization procedures in children. This
may lead to important differences in hospital mor-
tality rates and could possibly challenge the ﬁndings
in the study by O’Byrne et al. (3). Validation of the
accuracy of PHIS data and determination of the
relative merits of different data sources (adminis-
trative vs. registry) in the assessment of risks and
outcomes of cardiac catheterization in pediatric car-
diology are therefore warranted. With the recent
emergence of a large, dedicated national registry
for cardiac catheterization in congenital heart dise-
ase (15), it is likely that it will be possible to answer
these questions, while enabling complete case
ascertainment and appropriate adjustment for case
mix complexity. Efforts to ensure that large cathe-
terization registry datasets be made available for use
for outcomes assessment and quality improvement
activities will likely impact the outcomes of children
undergoing cardiac catheterization, both for PH and
for other serious cardiac conditions.
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